Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial von Schoeffski, Patrick, George, Suzanne, Heinrich, Michael C.C, Zalcberg, John R.R, Bauer, Sebastian, Gelderblom, Hans, Serrano, Cesar, Jones, Robin L.L, Attia, Steven, D'Amato, Gina, Chi, Ping, Reichardt, Peter, Becker, Claus, Shi, Kelvin, Meade, Julie, Ruiz-Soto, Rodrigo, Blay, Jean-Yves, von Mehren, Margaret

Volltext

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC) von Davis, Ian D., Efstathiou, Jason A., Fizazi, Karim, James, Nicholas D., Shore, Neal, Small, Eric, Sweeney, Christopher J., Tombal, Bertrand, Agarwal, Neeraj, Aparicio, Ana, Armstrong, Andrew J., Bastos, Diogo Assed, Attard, Gerhardt, Axcrona, Karol, Ayadi, Mouna, Bjartell, Anders, Blanchard, Pierre, Bulbul, Muhammad, Buttigliero, Consuelo, Caffo, Orazio, Castro, Elena, Chi, Kim N., Clarke, Caroline S., Clarke, Noel, de Bono, Johann S., De Santis, Maria, Duran, Ignacio, Ekeke, Onyeanunam N., El Nahas, Tamer I.H., Emmett, Louise, Fanti, Stefano, Fatiregun, Omolara A., Fong, Peter C.C., Fonteyne, Valerie, Fossati, Nicola, George, Daniel J., Gleave, Martin E., Gravis, Gwenaelle, Halabi, Susan, Heinrich, Daniel, Herrmann, Ken, Hofman, Michael S., Hope, Thomas A., Horvath, Lisa G., Hussain, Maha H.A., Jereczek-Fossa, Barbara Alicja, Jones, Robert J., Joshua, Anthony M., Kanesvaran, Ravindren, Keizman, Daniel, Khauli, Raja B., Kramer, Gero, Loeb, Stacy, Mahal, Brandon A., Maluf, Fernando C., Mateo, Joaquin, McDermott, Ray, McKay, Rana R., Mehra, Niven, Merseburger, Axel S., Morgans, Alicia K., Morris, Michael J., Mrabti, Hind, Mukherji, Deborah, Murphy, Declan G., Murthy, Vedang, Mutambirwa, Shingai B.A., Nguyen, Paul L., Oh, William K., Ost, Piet, O’Sullivan, Joe M., Padhani, Anwar R., Poon, Darren M.C., Pritchard, Colin C., Rabah, Danny M, Rathkopf, Dana, Reiter, Robert E., Renard-Penna, Raphaele, Saad, Fred, Sade, Juan Pablo, Sandhu, Shahneen, Schaeffer, Edward, Scher, Howard I., Sharifi, Nima, Skoneczna, Iwona A., Spratt, Daniel E., Suzuki, Hiroyoshi, Taplin, Mary-Ellen, Thellenberg-Karlsson, Camilla, Tilki, Derya, Türkeri, Levent N., Ürün, Yüksel, Vale, Claire L., Vapiwala, Neha, Walz, Jochen, Yamoah, Kosj, Ye, Dingwei, Yu, Evan Y., Zapatero, Almudena, Omlin, Aurelius

Volltext

Pembrolizumab (pembro) plus abiraterone acetate (abi) and prednisone (p) in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from K... von Ferrario, Cristiano, Piulats, Josep M., Linch, Mark David, Stoeckle, Michael, Laguerre, Brigitte, Arranz, José A., Todenhöfer, Tilman, Fong, Peter C.C., Berry, William R., Emmenegger, Urban, Mourey, Loic, Mar, Nataliya, Appleman, Leonard Joseph, Joshua, Anthony M., Conter, Henry Jacob, Li, Xin Tong, Schloss, Charles, Poehlein, Christian Heinrich, De Bono, Johann S., Yu, Evan Y.

Volltext

KEYNOTE-365 cohort A updated results: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) von Yu, Evan Y., Piulats, Josep M., Gravis, Gwenaelle, Laguerre, Brigitte, Arranz Arija, Jose Angel, Oudard, Stephane, Fong, Peter C.C., Kolinsky, Michael Paul, Augustin, Marinela, Feyerabend, Susan, Kam, Audrey E., Gurney, Howard, Tafreshi, Ali, Retz, Margitta, Berry, William R., Mar, Nataliya, Wu, Helen, Schloss, Charles, Poehlein, Christian Heinrich, De Bono, Johann S.

Volltext

Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC... von Massard, Christophe, Retz, Margitta, Hammerer, Peter, Quevedo, Fernando, Fong, Peter C.C., Berry, William R., Gurney, Howard, Piulats, Josep M., Joshua, Anthony M., Linch, Mark David, Kolinsky, Michael Paul, Romano, Emanuela, Sridhar, Srikala S., Conter, Henry Jacob, Augustin, Marinela, Wu, Helen, Schloss, Charles, Poehlein, Christian Heinrich, Yu, Evan Y.

Volltext

Keynote-365 cohort b: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant... von Massard, Christophe, Retz, Margitta, Hammerer, Peter, Quevedo, Fernando, Fong, Peter C.C., Berry, William R., Gurney, Howard, Piulats, Josep M., Joshua, Anthony, Linch, Mark David, Kolinsky, Michael, Romano, Emanuela, Sridhar, Srikala S., Conter, Henry Jacob, Augustin, Marinela, Wu, Haiyan, Schloss, Charles, Poehlein, Christian Heinrich, Yu, Evan Y.

Volltext